Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2020 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2020 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Open Access

Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review)

  • Authors:
    • Demetrios Petrakis
    • Denisa Margină
    • Konstantinos Tsarouhas
    • Fotios Tekos
    • Miriana Stan
    • Dragana Nikitovic
    • Demetrios Kouretas
    • Demetrios A. Spandidos
    • Aristidis Tsatsakis
  • View Affiliations / Copyright

    Affiliations: Laboratory of Toxicology, Medical School, University of Crete, 71409 Heraklion, Greece, ‘Carol Davila’ University of Medicine and Pharmacy, Faculty of Pharmacy, Department of Biochemistry, 020956 Bucharest, Romania, Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece, Department of Biochemistry‑Biotechnology, University of Thessaly, 41500 Larissa, Greece, ‘Carol Davila’ University of Medicine and Pharmacy, Faculty of Pharmacy, Department of Toxicology, 020956 Bucharest, Romania, Laboratory of Histology‑Embryology, School of Medicine, University of Crete, 71003 Heraklion, Greece, Laboratory of Clinical Virology, Medical School, University of Crete, 71110 Heraklion, Greece
    Copyright: © Petrakis et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 9-19
    |
    Published online on: May 5, 2020
       https://doi.org/10.3892/mmr.2020.11127
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Coronaviruses (CoVs), enveloped positive-sense RNA viruses, are a group of viruses that cause infections in the human respiratory tract, which can be characterized clinically from mild to fatal. The severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is the virus responsible. The global spread of COVID‑19 can be described as the worst pandemic in humanity in the last century. To date, COVID‑19 has infected more than 3,000,000 people worldwide and killed more than 200,000 people. All age groups can be infected from the virus, but more serious symptoms that can possibly result in death are observed in older people and those with underlying medical conditions such as cardiovascular and pulmonary disease. Novel data report more severe symptoms and even a negative prognosis for the obese patients. A growing body of evidence connects obesity with COVID‑19 and a number of mechanisms from immune system activity attenuation to chronic inflammation are implicated. Lipid peroxidation creates reactive lipid aldehydes which in a patient with metabolic disorder and COVID‑19 will affect its prognosis. Finally, pregnancy‑associated obesity needs to be studied further in connection to COVID‑19 as this infection could pose high risk both to pregnant women and the fetus.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, Moschos SA, Tsoukalas D, Goumenou M, Drakoulis N, et al: A new threat from an old enemy: Re emergence of coronavirus (Review). Int J Mol Med. 45:1631–1643. 2020.PubMed/NCBI

2 

Goumenou M, Sarigiannis D, Tsatsakis A, Anesti O, Docea AO, Petrakis D, Tsoukalas D, Kostoff R, Rakitskii V, Spandidos DA, et al: COVID 19 in Northern Italy: An integrative overview of factors possibly influencing the sharp increase of the outbreak (Review). Mol Med Rep. 22:20–32. 2020.PubMed/NCBI

3 

Centers for Disease Control and Prevention (CDC): Coronavirus Disease 2019 (COVID-19), . People who are at higher risk for severe illness. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/groups-at-higher-risk.htmlApril 15–2020

4 

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, et al: Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. Mar 13–2020.(Epub ahead of print). View Article : Google Scholar

5 

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 395:1054–1062. 2020. View Article : Google Scholar : PubMed/NCBI

6 

Muniyappa R and Gubbi S: COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 318:E736–E741. 2020. View Article : Google Scholar : PubMed/NCBI

7 

Moser JS, Galindo-Fraga A, Ortiz-Hernández AA, Gu W, Hunsberger S, Galán-Herrera JF, Guerrero ML, Ruiz-Palacios GM and Beigel JH; La Red ILI 002 Study Group, : Underweight, overweight, and obesity as independent risk factors for hospitalization in adults and children from influenza and other respiratory viruses. Influenza Other Respir Viruses. 13:3–9. 2019. View Article : Google Scholar : PubMed/NCBI

8 

Yuen KS, Ye ZW, Fung SY, Chan CP and Jin DY: SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 10:402020. View Article : Google Scholar : PubMed/NCBI

9 

Bornstein SR, Dalan R, Hopkins D, Mingrone G and Boehm BO: Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol. Apri 2–2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

10 

Drucker DJ: Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications. Endocr Rev. 41:bnaa0112020. View Article : Google Scholar : PubMed/NCBI

11 

Zhang W, Xu YZ, Liu B, Wu R, Yang YY, Xiao XQ and Zhang X: Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis. ScientificWorldJournal. 2014:6034092014.PubMed/NCBI

12 

Tikoo K, Patel G, Kumar S, Karpe PA, Sanghavi M, Malek V and Srinivasan K: Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications. Biochem Pharmacol. 93:343–351. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Romaní-Pérez M, Outeiriño-Iglesias V, Moya CM, Santisteban P, González-Matías LC, Vigo E and Mallo F: Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats. Endocrinology. 156:3559–3569. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Kulcsar KA, Coleman CM, Beck SE and Frieman MB: Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight. 4:1317742019. View Article : Google Scholar : PubMed/NCBI

15 

Petrakis D, Vassilopoulou L, Mamoulakis C, Psycharakis C, Anifantaki A, Sifakis S, Docea AO, Tsiaoussis J, Makrigiannakis A and Tsatsakis AM: Endocrine disruptors leading to obesity and related diseases. Int J Environ Res Public Health. 14:E12822017. View Article : Google Scholar : PubMed/NCBI

16 

Vassilopoulou L, Psycharakis C, Petrakis D, Tsiaoussis J and Tsatsakis AM: Obesity, persistent organic pollutants and related health problems. Adv Exp Med Biol. 960:81–110. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J and Feve B: Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 17:4–12. 2006.PubMed/NCBI

18 

Baltzis D, Meimeti E, Grammatikopoulou MG, Roustit M, Mavrogonatou E, Kletsas D, Efraimidou S, Manes C, Nikolouzakis TK, Tsiaoussis J, et al: Assessment of telomerase activity in leukocytes of type 2 diabetes mellitus patients having or not foot ulcer: Possible correlation with other clinical parameters. Exp Ther Med. 15:3420–3424. 2018.PubMed/NCBI

19 

Engin AB, Tsatsakis AM, Tsoukalas D and Engin A: Do flavanols-rich natural products relieve obesity-related insulin resistance? Food Chem Toxicol. 112:157–167. 2018. View Article : Google Scholar : PubMed/NCBI

20 

Ungurianu A, Margină D, Grădinaru D, Băcanu C, Ilie M, Tsitsimpikou C, Tsarouhas K, Spandidos DA and Tsatsakis AM: Lipoprotein redox status evaluation as a marker of cardiovascular disease risk in patients with inflammatory disease. Mol Med Rep. 15:256–262. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Zimmet P, Alberti KG and Shaw J: Global and societal implications of the diabetes epidemic. Nature. 414:782–787. 2001. View Article : Google Scholar : PubMed/NCBI

22 

Tilg H: The role of cytokines in non-alcoholic fatty liver disease. Dig Dis. 28:179–185. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Tilg H and Moschen AR: Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 6:772–783. 2006. View Article : Google Scholar : PubMed/NCBI

24 

Gomes F, Telo DF, Souza HP, Nicolau JC, Halpern A and Serrano CV Jr: Obesity and coronary artery disease: role of vascular inflammation. Arq Bras Cardiol. 94:255–266. 2010.(In English, Portuguese, Spanish). PubMed/NCBI

25 

Ungurianu A, Şeremet O, Gagniuc E, Olaru OT, Guţu C, Grǎdinaru D, Ionescu-Tȋrgovişte C, Marginǎ D and Dǎnciulescu-Miulescu R: Preclinical and clinical results regarding the effects of a plant-based antidiabetic formulation versus well established antidiabetic molecules. Pharmacol Res. 150:1045222019. View Article : Google Scholar : PubMed/NCBI

26 

Procaccini C, Carbone F, Galgani M, La Rocca C, De Rosa V, Cassano S and Matarese G: Obesity and susceptibility to autoimmune diseases. Expert Rev Clin Immunol. 7:287–294. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Denes A, Thornton P, Rothwell NJ and Allan SM: Inflammation and brain injury: Acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun. 24:708–723. 2010. View Article : Google Scholar : PubMed/NCBI

28 

Ohman MK, Wright AP, Wickenheiser KJ, Luo W and Eitzman DT: Visceral adipose tissue and atherosclerosis. Curr Vasc Pharmacol. 7:169–179. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Wolin KY, Carson K and Colditz GA: Obesity and cancer. Oncologist. 15:556–565. 2010. View Article : Google Scholar : PubMed/NCBI

30 

Mangge H, Almer G, Truschnig-Wilders M, Schmidt A, Gasser R and Fuchs D: Inflammation, adiponectin, obesity and cardiovascular risk. Curr Med Chem. 17:4511–4520. 2010. View Article : Google Scholar : PubMed/NCBI

31 

Tsoukalas D, Alegakis A, Fragkiadaki P, Papakonstantinou E, Nikitovic D, Karataraki A, Nosyrev AE, Papadakis EG, Spandidos DA, Drakoulis N, et al: Application of metabolomics: Focus on the quantification of organic acids in healthy adults. Int J Mol Med. 40:112–120. 2017. View Article : Google Scholar : PubMed/NCBI

32 

Tsoukalas D, Alegakis AK, Fragkiadaki P, Papakonstantinou E, Tsilimidos G, Geraci F, Sarandi E, Nikitovic D, Spandidos DA and Tsatsakis A: Application of metabolomics part II: Focus on fatty acids and their metabolites in healthy adults. Int J Mol Med. 43:233–242. 2019.PubMed/NCBI

33 

Tsoukalas D, Fragoulakis V, Sarandi E, Docea AO, Papakonstaninou E, Tsilimidos G, Anamaterou C, Fragkiadaki P, Aschner M, Tsatsakis A, et al: Targeted metabolomic analysis of serum fatty acids for the prediction of autoimmune diseases. Front Mol Biosci. 6:1202019. View Article : Google Scholar : PubMed/NCBI

34 

Smethers AD and Rolls BJ: Dietary management of obesity: Cornerstones of healthy eating patterns. Med Clin North Am. 102:107–124. 2018. View Article : Google Scholar : PubMed/NCBI

35 

Pérez-Escamilla R, Obbagy JE, Altman JM, Essery EV, McGrane MM, Wong YP, Spahn JM and Williams CL: Dietary energy density and body weight in adults and children: A systematic review. J Acad Nutr Diet. 112:671–684. 2012. View Article : Google Scholar : PubMed/NCBI

36 

Arango-Angarita A, Rodríguez-Ramírez S, Serra-Majem L and Shamah-Levy T: Dietary energy density and its association with overweight or obesity in adolescents: A systematic review of observational studies. Nutrients. 10:E16122018. View Article : Google Scholar : PubMed/NCBI

37 

Patterson E, Wärnberg J, Poortvliet E, Kearney JM and Sjöström M: Dietary energy density as a marker of dietary quality in Swedish children and adolescents: The European Youth Heart Study. Eur J Clin Nutr. 64:356–363. 2010. View Article : Google Scholar : PubMed/NCBI

38 

Rouhani MH, Haghighatdoost F, Surkan PJ and Azadbakht L: Associations between dietary energy density and obesity: A systematic review and meta-analysis of observational studies. Nutrition. 32:1037–1047. 2016. View Article : Google Scholar : PubMed/NCBI

39 

Sassi F, Tamone C and D'Amelio P: Vitamin D: Nutrient, hormone, and immunomodulator. Nutrients. 10:E16562018. View Article : Google Scholar : PubMed/NCBI

40 

Lee GY and Han SN: The role of vitamin E in immunity. Nutrients. 10:E16142018. View Article : Google Scholar : PubMed/NCBI

41 

Avery JC and Hoffmann PR: Selenium, selenoproteins, and immunity. Nutrients. 10:E12032018. View Article : Google Scholar : PubMed/NCBI

42 

Manzel A, Muller DN, Hafler DA, Erdman SE, Linker RA and Kleinewietfeld M: Role of ‘Western diet’ in inflammatory autoimmune diseases. Curr Allergy Asthma Rep. 14:4042014. View Article : Google Scholar : PubMed/NCBI

43 

Papandreou C, Schiza SE, Tzatzarakis MN, Kavalakis M, Hatzis CM, Tsatsakis AM, Kafatos AG, Siafakas NM and Tzanakis NE: Effect of Mediterranean diet on lipid peroxidation marker TBARS in obese patients with OSAHS under CPAP treatment: a randomised trial. Sleep Breath. 16:873–879. 2012. View Article : Google Scholar : PubMed/NCBI

44 

Tsarouhas A, Soufla G, Tsarouhas K, Katonis P, Pasku D, Vakis A, Tsatsakis AM and Spandidos DA: Molecular profile of major growth factors in lumbar intervertebral disc herniation: Correlation with patient clinical and epidemiological characteristics. Mol Med Rep. 15:2195–2203. 2017. View Article : Google Scholar : PubMed/NCBI

45 

Gradinaru D, Margina D, Borsa C, Ionescu C, Ilie M, Costache M, Dinischiotu A and Prada GI: Adiponectin: Possible link between metabolic stress and oxidative stress in the elderly. Aging Clin Exp Res. 29:621–629. 2017. View Article : Google Scholar : PubMed/NCBI

46 

Gaforio JJ, Visioli F, Alarcón-de-la-Lastra C, Castañer O, Delgado-Rodríguez M, Fitó M, Hernández AF, Huertas JR, Martínez-González MA, Menendez JA, et al: Virgin olive oil and health: Summary of the III International Conference on Virgin Olive Oil and Health Consensus Report, JAEN (Spain) 2018. Nutrients. 11:E20392019. View Article : Google Scholar : PubMed/NCBI

47 

Margina D, Ilie M and Gradinaru D: Quercetin and epigallocatechin gallate induce in vitro a dose-dependent stiffening and hyperpolarizing effect on the cell membrane of human mononuclear blood cells. Int J Mol Sci. 13:4839–4859. 2012. View Article : Google Scholar : PubMed/NCBI

48 

Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg H, Watson A and Wells JM: Intestinal permeability - a new target for disease prevention and therapy. BMC Gastroenterol. 14:1892014. View Article : Google Scholar : PubMed/NCBI

49 

Timmermans S, Bogie JF, Vanmierlo T, Lütjohann D, Stinissen P, Hellings N and Hendriks JJ: High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the renin angiotensin system. J Neuroimmune Pharmacol. 9:209–217. 2014. View Article : Google Scholar : PubMed/NCBI

50 

Jhun JY, Yoon BY, Park MK, Oh HJ, Byun JK, Lee SY, Min JK, Park SH, Kim HY and Cho ML: Obesity aggravates the joint inflammation in a collagen-induced arthritis model through deviation to Th17 differentiation. Exp Mol Med. 44:424–431. 2012. View Article : Google Scholar : PubMed/NCBI

51 

Paik J, Fierce Y, Treuting PM, Brabb T and Maggio-Price L: High-fat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a-/- male mice. J Nutr. 143:1240–1247. 2013. View Article : Google Scholar : PubMed/NCBI

52 

Klack K, Bonfa E and Borba Neto EF: Diet and nutritional aspects in systemic lupus erythematosus. Rev Bras Reumatol. 52:384–408. 2012.PubMed/NCBI

53 

De Rosa V, Procaccini C, La Cava A, Chieffi P, Nicoletti GF, Fontana S, Zappacosta S and Matarese G: Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. J Clin Invest. 116:447–455. 2006. View Article : Google Scholar : PubMed/NCBI

54 

Cipolletta D, Feuerer M, Li A, Kamei N, Lee J, Shoelson SE, Benoist C and Mathis D: PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature. 486:549–553. 2012. View Article : Google Scholar : PubMed/NCBI

55 

Grimes CA, Bolhuis DP, He FJ and Nowson CA: Dietary sodium intake and overweight and obesity in children and adults: A protocol for a systematic review and meta-analysis. Syst Rev. 5:72016. View Article : Google Scholar : PubMed/NCBI

56 

Savica V, Bellinghieri G and Kopple JD: The effect of nutrition on blood pressure. Annu Rev Nutr. 30:365–401. 2010. View Article : Google Scholar : PubMed/NCBI

57 

Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, Muller DN and Hafler DA: Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature. 496:518–522. 2013. View Article : Google Scholar : PubMed/NCBI

58 

Kino T, Takatori H, Manoli I, Wang Y, Tiulpakov A, Blackman MR, Su YA, Chrousos GP, DeCherney AH and Segars JH: Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5. Sci Signal. 2:ra52009. View Article : Google Scholar : PubMed/NCBI

59 

Woehrle T, Yip L, Manohar M, Sumi Y, Yao Y, Chen Y and Junger WG: Hypertonic stress regulates T cell function via pannexin-1 hemichannels and P2X receptors. J Leukoc Biol. 88:1181–1189. 2010. View Article : Google Scholar : PubMed/NCBI

60 

Musso G, Gambino R and Cassader M: Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med. 62:361–380. 2011. View Article : Google Scholar : PubMed/NCBI

61 

Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, Cooper J, Sin DD, Mohn WW and Hogg JC: The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 185:1073–1080. 2012. View Article : Google Scholar : PubMed/NCBI

62 

Greenblum S, Turnbaugh PJ and Borenstein E: Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci USA. 109:594–599. 2012. View Article : Google Scholar : PubMed/NCBI

63 

Tkacova R: Systemic inflammation in chronic obstructive pulmonary disease: May adipose tissue play a role? Review of the literature and future perspectives. Mediators Inflamm. 2010:5859892010. View Article : Google Scholar : PubMed/NCBI

64 

Jiang F, Deng L, Zhang L, Cai Y, Cheung CW and Xia Z: Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med. Mar 4–2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

65 

Huang R, Zhu L, Xue L, Liu L, Yan X, Wang J, Zhang B, Xu T, Ji F, Zhao Y, Cheng J, et al: Clinical findings of patients with Coronavirus Disease 2019 in Jiangsu Province, China: A Retrospective, Multi-Center Study. SSRN. http://dx.doi.org/10.2139/ssrn.3548785 View Article : Google Scholar

66 

Petrilli CM, Jones SA, Yang JJ, Rajagopalan H, O'Donnell LF, Chernyak Y, Tobin K, Cerfolio RJ, Francois F and Horwitz LI: Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City. medRxiv. https://doi.org/10.1101/2020.04.08.20057794 View Article : Google Scholar

67 

Miles EA, Rees D, Banerjee T, Cazzola R, Lewis S, Wood R, Oates R, Tallant A, Cestaro B, Yaqoob P, et al: Age-related increases in circulating inflammatory markers in men are independent of BMI, blood pressure and blood lipid concentrations. Atherosclerosis. 196:298–305. 2008. View Article : Google Scholar : PubMed/NCBI

68 

Crooke SN, Ovsyannikova IG, Poland GA and Kennedy RB: Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses. Exp Gerontol. 124:1106322019. View Article : Google Scholar : PubMed/NCBI

69 

Leonarduzzi G, Gamba P, Gargiulo S, Biasi F and Poli G: Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis. Free Radic Biol Med. 52:19–34. 2012. View Article : Google Scholar : PubMed/NCBI

70 

Berzins SP, Uldrich AP, Sutherland JS, Gill J, Miller JF, Godfrey DI and Boyd RL: Thymic regeneration: Teaching an old immune system new tricks. Trends Mol Med. 8:469–476. 2002. View Article : Google Scholar : PubMed/NCBI

71 

Maggini S, Pierre A and Calder PC: Immune function and micronutrient requirements change over the life course. Nutrients. 10:E15312018. View Article : Google Scholar : PubMed/NCBI

72 

Salanitro AH, Ritchie CS, Hovater M, Roth DL, Sawyer P, Locher JL, Bodner E, Brown CJ and Allman RM: Inflammatory biomarkers as predictors of hospitalization and death in community-dwelling older adults. Arch Gerontol Geriatr. 54:e387–e391. 2012. View Article : Google Scholar : PubMed/NCBI

73 

Wadhwa PD, Buss C, Entringer S and Swanson JM: Developmental origins of health and disease: Brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 27:358–368. 2009. View Article : Google Scholar : PubMed/NCBI

74 

Jirtle RL and Skinner MK: Environmental epigenomics and disease susceptibility. Nat Rev Genet. 8:253–262. 2007. View Article : Google Scholar : PubMed/NCBI

75 

Evans AC, Papachristou GI and Whitcomb DC: Obesity and the risk of severe acute pancreatitis. Minerva Gastroenterol Dietol. 56:169–179. 2010.PubMed/NCBI

76 

Alam I, Ng TP and Larbi A: Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective. Mediators Inflamm. 2012:4564562012. View Article : Google Scholar : PubMed/NCBI

77 

Sharabiani MT, Vermeulen R, Scoccianti C, Hosnijeh FS, Minelli L, Sacerdote C, Palli D, Krogh V, Tumino R, Chiodini P, et al: Immunologic profile of excessive body weight. Biomarkers. 16:243–251. 2011. View Article : Google Scholar : PubMed/NCBI

78 

Elias CF, Aschkenasi C, Lee C, Kelly J, Ahima RS, Bjorbaek C, Flier JS, Saper CB and Elmquist JK: Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron. 23:775–786. 1999. View Article : Google Scholar : PubMed/NCBI

79 

Forny-Germano L, De Felice FG and Vieira MNDN: The role of leptin and adiponectin in obesity-associated cognitive decline and Alzheimer's disease. Front Neurosci. 12:10272019. View Article : Google Scholar : PubMed/NCBI

80 

Honce R and Schultz-Cherry S: Impact of obesity on influenza A virus pathogenesis, immune response, and evolution. Front Immunol. 10:10712019. View Article : Google Scholar : PubMed/NCBI

81 

Katsikantami I, Sifakis S, Tzatzarakis MN, Vakonaki E, Kalantzi OI, Tsatsakis AM and Rizos AK: A global assessment of phthalates burden and related links to health effects. Environ Int. 97:212–236. 2016. View Article : Google Scholar : PubMed/NCBI

82 

Burgio E, Lopomo A and Migliore L: Obesity and diabetes: From genetics to epigenetics. Mol Biol Rep. 42:799–818. 2015. View Article : Google Scholar : PubMed/NCBI

83 

Katsarou MS, Karathanasopoulou A, Andrianopoulou A, Desiniotis V, Tzinis E, Dimitrakis E, Lagiou M, Charmandari E, Aschner M, Tsatsakis AM, et al: Beta 1, Beta 2 and Beta 3 Adrenergic receptor gene polymorphisms in a Southeastern European population. Front Genet. 9:5602018. View Article : Google Scholar : PubMed/NCBI

84 

Eliakim A, Schwindt C, Zaldivar F, Casali P and Cooper DM: Reduced tetanus antibody titers in overweight children. Autoimmunity. 39:137–141. 2006. View Article : Google Scholar : PubMed/NCBI

85 

Neuendorf R, Corn J, Hanes D and Bradley R: Impact of food immunoglobulin G-based elimination diet on subsequent food immunoglobulin G and quality of life in overweight/obese adults. J Altern Complement Med. 25:241–248. 2019. View Article : Google Scholar : PubMed/NCBI

86 

Poutahidis T, Kleinewietfeld M, Smillie C, Levkovich T, Perrotta A, Bhela S, Varian BJ, Ibrahim YM, Lakritz JR, Kearney SM, et al: Microbial reprogramming inhibits Western diet-associated obesity. PLoS One. 8:e685962013. View Article : Google Scholar : PubMed/NCBI

87 

Winer S, Paltser G, Chan Y, Tsui H, Engleman E, Winer D and Dosch HM: Obesity predisposes to Th17 bias. Eur J Immunol. 39:2629–2635. 2009. View Article : Google Scholar : PubMed/NCBI

88 

Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, Svistunov AA, Petrakis D, Spandidos DA, Aaseth J, et al: Zinc and respiratory tract infections: Perspectives for COVID-19 (Review). Int J Mol Med. Apr 14–2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

89 

Sumarac-Dumanovic M, Stevanovic D, Ljubic A, Jorga J, Simic M, Stamenkovic-Pejkovic D, Starcevic V, Trajkovic V and Micic D: Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes. 33:151–156. 2009. View Article : Google Scholar

90 

Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, Herman WH, Holman RR, Jones NP, et al ADOPT Study Group, : Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes. 55:2357–2364. 2006. View Article : Google Scholar : PubMed/NCBI

91 

Wittekindt OH: Tight junctions in pulmonary epithelia during lung inflammation. Pflugers Arch. 469:135–147. 2017. View Article : Google Scholar : PubMed/NCBI

92 

Ahmed M and Gaffen SL: IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev. 21:449–453. 2010. View Article : Google Scholar : PubMed/NCBI

93 

Zambrano-Zaragoza JF, Romo-Martínez EJ, Durán-Avelar MJ, García-Magallanes N and Vibanco-Pérez N: Th17 cells in autoimmune and infectious diseases. Int J Inflamm. 2014:6515032014. View Article : Google Scholar

94 

Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramírez P, Martin-Loeches I, Varillas D, Gallegos MC, Serón C, et al: Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care. 13:R2012009. View Article : Google Scholar : PubMed/NCBI

95 

Strissel KJ, DeFuria J, Shaul ME, Bennett G, Greenberg AS and Obin MS: T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice. Obesity (Silver Spring). 18:1918–1925. 2010. View Article : Google Scholar : PubMed/NCBI

96 

Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, Sun R, Tian Z, Xu X and Wei H: Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. Natl Sci Rev. doi:10.1093/nsr/nwaa041.

97 

Fang L, Karakiulakis G and Roth M: Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 8:e212020. View Article : Google Scholar : PubMed/NCBI

98 

Favalli EG, Ingegnoli F, De Lucia O, Cincinelli G, Cimaz R and Caporali R: COVID-19 infection and rheumatoid arthritis: Faraway, so close! Autoimmun Rev. 19(102523)2020.

99 

Andersen LB, Przybyl L, Haase N, von Versen-Höynck F, Qadri F, Jørgensen JS, Sorensen GL, Fruekilde P, Poglitsch M, Szijarto I, et al: Vitamin D depletion aggravates hypertension and target-organ damage. J Am Heart Assoc. 4:e0014172015. View Article : Google Scholar : PubMed/NCBI

100 

Santos RA, Ferreira AJ, Verano-Braga T and Bader M: Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: New players of the renin-angiotensin system. J Endocrinol. 216:R1–R17. 2013. View Article : Google Scholar : PubMed/NCBI

101 

Ames BN: Prolonging healthy aging: Longevity vitamins and proteins. Proc Natl Acad Sci USA. 115:10836–10844. 2018. View Article : Google Scholar : PubMed/NCBI

102 

Costa C, Tsatsakis A, Mamoulakis C, Teodoro M, Briguglio G, Caruso E, Tsoukalas D, Margina D, Dardiotis E, Kouretas D, et al: Current evidence on the effect of dietary polyphenols intake on chronic diseases. Food Chem Toxicol. 110:286–299. 2017. View Article : Google Scholar : PubMed/NCBI

103 

Hernandez JP, Mota LC and Baldwin WS: Activation of CAR and PXR by dietary, environmental and occupational chemicals alters drug metabolism, intermediary metabolism, and cell proliferation. Curr Pharmacogenomics Person Med. 7:81–105. 2009. View Article : Google Scholar : PubMed/NCBI

104 

Krzyżowska M, Wincenciak M, Winnicka A, Baranowski A, Jaszczak K, Zimny J and Niemiałtowski M: The effect of multigenerational diet containing genetically modified triticale on immune system in mice. Pol J Vet Sci. 13:423–430. 2010.PubMed/NCBI

105 

Lack G: Clinical risk assessment of GM foods. Toxicol Lett. 127:337–340. 2002. View Article : Google Scholar : PubMed/NCBI

106 

van Herpen NA and Schrauwen-Hinderling VB: Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav. 94:231–241. 2008. View Article : Google Scholar : PubMed/NCBI

107 

Li C, Ford ES, Mokdad AH, Balluz LS, Brown DW and Giles WH: Clustering of cardiovascular disease risk factors and health-related quality of life among US adults. Value Health. 11:689–699. 2008. View Article : Google Scholar : PubMed/NCBI

108 

Garbarino J and Sturley SL: Saturated with fat: New perspectives on lipotoxicity. Curr Opin Clin Nutr Metab Care. 12:110–116. 2009. View Article : Google Scholar : PubMed/NCBI

109 

Bosma M, Kersten S, Hesselink MK and Schrauwen P: Re-evaluating lipotoxic triggers in skeletal muscle: Relating intramyocellular lipid metabolism to insulin sensitivity. Prog Lipid Res. 51:36–49. 2012. View Article : Google Scholar : PubMed/NCBI

110 

Unger RH and Scherer PE: Gluttony, sloth and the metabolic syndrome: A roadmap to lipotoxicity. Trends Endocrinol Metab. 21:345–352. 2010. View Article : Google Scholar : PubMed/NCBI

111 

Sies H: Oxidative Stress. (1st). Academic Press. 1985.

112 

Jones DP: Redefining oxidative stress. Antioxid Redox Signal. 8:1865–1879. 2006. View Article : Google Scholar : PubMed/NCBI

113 

Benedetti A, Comporti M and Esterbauer H: Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta. 620:281–296. 1980. View Article : Google Scholar : PubMed/NCBI

114 

Hauck AK and Bernlohr DA: Oxidative stress and lipotoxicity. J Lipid Res. 57:1976–1986. 2016. View Article : Google Scholar : PubMed/NCBI

115 

Barrera G, Pizzimenti S, Ciamporcero ES, Daga M, Ullio C, Arcaro A, Cetrangolo GP, Ferretti C, Dianzani C, Lepore A and Gentile F: Role of 4-hydroxynonenal-protein adducts in human diseases. Antioxid Redox Signal. 22:1681–1702. 2015. View Article : Google Scholar : PubMed/NCBI

116 

Grimsrud PA, Picklo MJ Sr, Griffin TJ and Bernlohr DA: Carbonylation of adipose proteins in obesity and insulin resistance: Identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol Cell Proteomics. 6:624–637. 2007. View Article : Google Scholar : PubMed/NCBI

117 

Wagner TM, Mullally JE and Fitzpatrick FA: Reactive lipid species from cyclooxygenase-2 inactivate tumor suppressor LKB1/STK11: Cyclopentenone prostaglandins and 4-hydroxy-2-nonenal covalently modify and inhibit the AMP-kinase kinase that modulates cellular energy homeostasis and protein translation. J Biol Chem. 281:2598–2604. 2006. View Article : Google Scholar : PubMed/NCBI

118 

Barreiro E, del Puerto-Nevado L, Puig-Vilanova E, Pérez-Rial S, Sánchez F, Martínez-Galán L, Rivera S, Gea J, González-Mangado N and Peces-Barba G: Cigarette smoke-induced oxidative stress in skeletal muscles of mice. Respir Physiol Neurobiol. 182:9–17. 2012. View Article : Google Scholar : PubMed/NCBI

119 

Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR and Butterfield DA: Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med. 33:562–571. 2002. View Article : Google Scholar : PubMed/NCBI

120 

Dalle-Donne I, Rossi R, Giustarini D, Milzani A and Colombo R: Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 329:23–38. 2003. View Article : Google Scholar : PubMed/NCBI

121 

Pirinccioglu AG, Gökalp D, Pirinccioglu M, Kizil G and Kizil M: Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia. Clin Biochem. 43:1220–1224. 2010. View Article : Google Scholar : PubMed/NCBI

122 

Leonarduzzi G, Chiarpotto E, Biasi F and Poli G: 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res. 49:1044–1049. 2005. View Article : Google Scholar : PubMed/NCBI

123 

Zarkovic K: 4-hydroxynonenal and neurodegenerative diseases. Mol Aspects Med. 24:293–303. 2003. View Article : Google Scholar : PubMed/NCBI

124 

Kassir R: Risk of COVID-19 for patients with obesity. Obes Rev. Apr 13–2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

125 

Zhu Y, Ren C, Zhang M and Zhong Y: Perilipin 5 reduces oxidative damage associated with lipotoxicity by activating the PI3K/ERK-mediated Nrf2-ARE signaling pathway in INS-1 pancreatic β-cells. Front Endocrinol (Lausanne). 11:1662020. View Article : Google Scholar : PubMed/NCBI

126 

Misumi I, Starmer J, Uchimura T, Beck MA, Magnuson T and Whitmire JK: Obesity expands a distinct population of T cells in adipose tissue and increases vulnerability to infection. Cell Rep. 27:514–524.e5. 2019. View Article : Google Scholar : PubMed/NCBI

127 

Bourgeois C, Gorwood J, Barrail-Tran A, Lagathu C, Capeau J, Desjardins D, Le Grand R, Damouche A, Béréziat V and Lambotte O: Specific biological features of adipose tissue, and their impact on HIV persistence. Front Microbiol. 10:28372019. View Article : Google Scholar : PubMed/NCBI

128 

Ryan PM and Caplice NM: Is adipose tissue a reservoir for viral spread, immune activation and cytokine amplification in COVID-19. Obesity (Silver Spring). Apr 21–2020.(Epub ahead of print). View Article : Google Scholar

129 

Venkata C, Sampathkumar P and Afessa B: Hospitalized patients with 2009 H1N1 influenza infection: The Mayo Clinic experience. Mayo Clin Proc. 85:798–805. 2010. View Article : Google Scholar : PubMed/NCBI

130 

Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, Vugia D, Harriman K, Matyas B, Glaser CA, et al California Pandemic (H1N1) Working Group, : Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 302:1896–1902. 2009. View Article : Google Scholar : PubMed/NCBI

131 

Thompson DL, Jungk J, Hancock E, Smelser C, Landen M, Nichols M, Selvage D, Baumbach J and Sewell M: Risk factors for 2009 pandemic influenza A (H1N1)-related hospitalization and death among racial/ethnic groups in New Mexico. Am J Public Health. 101:1776–1784. 2011. View Article : Google Scholar : PubMed/NCBI

132 

Dietz W and Santos-Burgoa C: Obesity and its implications for COVID-19 mortality. Obesity (Silver Spring). Apr 1–2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

133 

Sun Y, Wang Q, Yang G, Lin C, Zhang Y and Yang P: Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: A systematic review of observational studies with meta-analysis. Infect Dis (Lond). 48:813–822. 2016. View Article : Google Scholar : PubMed/NCBI

134 

Liu M, He P, Liu HG, Wang XJ, Li FJ, Chen S, Lin J, Chen P, Liu JH and Li CH: Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 43(E016)2020.(In Chinese).

135 

Peng YD, Meng K, Guan HQ, Leng L, Zhu RR, Wang BY, He MA, Cheng LX, Huang K and Zeng QT: Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Zhonghua Xin Xue Guan Bing Za Zhi. 48(E004)2020.(In Chinese).

136 

Verdecchia P, Cavallini C, Spanevello A and Angeli F: The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. Apr 20–2020.(Epub ahead of print). View Article : Google Scholar

137 

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181:271–280.e8. 2020. View Article : Google Scholar : PubMed/NCBI

138 

Hussain M, Jabeen N, Raza F, Shabbir S, Baig AA, Amanullah A and Aziz B: Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. J Med Virol. Apr 6–2020.(Epub ahead of print). View Article : Google Scholar

139 

Santos RA and Ferreira AJ: Angiotensin-(1–7) and the renin-angiotensin system. Curr Opin Nephrol Hypertens. 16:122–128. 2007. View Article : Google Scholar : PubMed/NCBI

140 

Cavalera M, Wang J and Frangogiannis NG: Obesity, metabolic dysfunction, and cardiac fibrosis: Pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. Transl Res. 164:323–335. 2014. View Article : Google Scholar : PubMed/NCBI

141 

Senador D, Kanakamedala K, Irigoyen MC, Morris M and Elased KM: Cardiovascular and autonomic phenotype of db/db diabetic mice. Exp Physiol. 94:648–658. 2009. View Article : Google Scholar : PubMed/NCBI

142 

Alpert MA, Omran J, Mehra A and Ardhanari S: Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis. 56:391–400. 2014. View Article : Google Scholar : PubMed/NCBI

143 

Touyz RM, Savoia C, He Y, Endemann D, Pu Q, Ko EA, Deciuceis C, Montezano A and Schiffrin EL: Increased inflammatory biomarkers in hypertensive type 2 diabetic patients: Improvement after angiotensin II type 1 receptor blockade. J Am Soc Hypertens. 1:189–199. 2007. View Article : Google Scholar : PubMed/NCBI

144 

Lumeng CN and Saltiel AR: Inflammatory links between obesity and metabolic disease. J Clin Invest. 121:2111–2117. 2011. View Article : Google Scholar : PubMed/NCBI

145 

World Health Organization (WHO), . Advice on the use of masks in the context of COVID-19: interim guidance. 6–April;2020.WHO. (Geneva). 2020.

146 

World Health Organization (WHO), . Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages: interim guidance. 6–April;2020.WHO. (Geneva). 2020.

147 

Marcus Y, Shefer G and Stern N: Adipose tissue renin-angiotensin-aldosterone system (RAAS) and progression of insulin resistance. Mol Cell Endocrinol. 378:1–14. 2013. View Article : Google Scholar : PubMed/NCBI

148 

Jose RJ and Manuel A: Does COVID-19 disprove the obesity paradox in ARDS? Obesity (Silver Spring). Apr 15–2020.(Epub ahead of print). PubMed/NCBI

149 

O'Brien JM Jr, Phillips GS, Ali NA, Lucarelli M, Marsh CB and Lemeshow S: Body mass index is independently associated with hospital mortality in mechanically ventilated adults with acute lung injury. Crit Care Med. 34:738–744. 2006. View Article : Google Scholar : PubMed/NCBI

150 

Fernandez-Bustamante A and Repine J: Adipose-lung cell crosstalk in the obesity-ARDS paradox. J Pulm Respir Med. 3:1442013.

151 

Nie W, Zhang Y, Jee SH, Jung KJ, Li B and Xiu Q: Obesity survival paradox in pneumonia: A meta-analysis. BMC Med. 12:612014. View Article : Google Scholar : PubMed/NCBI

152 

Stefan N, Birkenfeld AL, Schulze MB and Ludwig DS: Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol. Apr 23–2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

153 

Akoumianakis I, Akawi N and Antoniades C: Exploring the crosstalk between adipose tissue and the cardiovascular system. Korean Circ J. 47:670–685. 2017. View Article : Google Scholar : PubMed/NCBI

154 

Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, Labreuche J, Mathieu D, Pattou F and Jourdain M; Lille Intensive Care COVID-19 and Obesity study Group, : High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). Apr 9–2020.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

155 

Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F and Stachel A: Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin Infect Dis ciaa. 415:2020.

156 

Lederman MM: Cell-mediated immunity and pregnancy. Chest. 86 (Suppl 3):6S–9S. 1984. View Article : Google Scholar : PubMed/NCBI

157 

Harris JW: Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAMA. 72:978–980. 1919. View Article : Google Scholar

158 

Greenberg M, Jacobziner H, Pakter J and Weisl BA: Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am J Obstet Gynecol. 76:897–902. 1958. View Article : Google Scholar : PubMed/NCBI

159 

Klein SL, Passaretti C, Anker M, Olukoya P and Pekosz A: The impact of sex, gender and pregnancy on 2009 H1N1 disease. Biol Sex Differ. 1:52010. View Article : Google Scholar : PubMed/NCBI

160 

Harger JH, Ernest JM, Thurnau GR, Moawad A, Momirova V, Landon MB, Paul R, Miodovnik M, Dombrowski M, Sibai B, et al; National Institute of Child Health and Human Development, Network of Maternal-Fetal Medicine Units, . Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis. 185:422–427. 2002. View Article : Google Scholar : PubMed/NCBI

161 

Braden CR: Listeriosis. Pediatr Infect Dis J. 22:745–746. 2003. View Article : Google Scholar : PubMed/NCBI

162 

Shulman CE and Dorman EK: Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg. 97:30–35. 2003. View Article : Google Scholar : PubMed/NCBI

163 

Stockman LJ, Lowther SA, Coy K, Saw J and Parashar UD: SARS during pregnancy, United States. Emerg Infect Dis. 10:1689–1690. 2004. View Article : Google Scholar : PubMed/NCBI

164 

Neuzil KM, Reed GW, Mitchel EF, Simonsen L and Griffin MR: Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 148:1094–1102. 1998. View Article : Google Scholar : PubMed/NCBI

165 

Irving WL, James DK, Stephenson T, Laing P, Jameson C, Oxford JS, Chakraverty P, Brown DW, Boon AC and Zambon MC: Influenza virus infection in the second and third trimesters of pregnancy: A clinical and seroepidemiological study. BJOG. 107:1282–1289. 2000. View Article : Google Scholar : PubMed/NCBI

166 

Moynihan AT, Hehir MP, Glavey SV, Smith TJ and Morrison JJ: Inhibitory effect of leptin on human uterine contractility in vitro. Am J Obstet Gynecol. 195:504–509. 2006. View Article : Google Scholar : PubMed/NCBI

167 

Mor G and Cardenas I: The immune system in pregnancy: A unique complexity. Am J Reprod Immunol. 63:425–433. 2010. View Article : Google Scholar : PubMed/NCBI

168 

Kraus TA, Engel SM, Sperling RS, Kellerman L, Lo Y, Wallenstein S, Escribese MM, Garrido JL, Singh T, Loubeau M, et al: Characterizing the pregnancy immune phenotype: Results of the viral immunity and pregnancy (VIP) study. J Clin Immunol. 32:300–311. 2012. View Article : Google Scholar : PubMed/NCBI

169 

Rodríguez-García M, Oliva H, Climent N, García F, Gatell JM and Gallart T: Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1–3. J Leukoc Biol. 82:1143–1146. 2007. View Article : Google Scholar : PubMed/NCBI

170 

Wegmann TG, Lin H, Guilbert L and Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon? Immunol Today. 14:353–356. 1993. View Article : Google Scholar : PubMed/NCBI

171 

White SH, Wimley WC and Selsted ME: Structure, function, and membrane integration of defensins. Curr Opin Struct Biol. 5:521–527. 1995. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Petrakis D, Margină D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, Kouretas D, Spandidos DA and Tsatsakis A: Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review). Mol Med Rep 22: 9-19, 2020.
APA
Petrakis, D., Margină, D., Tsarouhas, K., Tekos, F., Stan, M., Nikitovic, D. ... Tsatsakis, A. (2020). Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review). Molecular Medicine Reports, 22, 9-19. https://doi.org/10.3892/mmr.2020.11127
MLA
Petrakis, D., Margină, D., Tsarouhas, K., Tekos, F., Stan, M., Nikitovic, D., Kouretas, D., Spandidos, D. A., Tsatsakis, A."Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review)". Molecular Medicine Reports 22.1 (2020): 9-19.
Chicago
Petrakis, D., Margină, D., Tsarouhas, K., Tekos, F., Stan, M., Nikitovic, D., Kouretas, D., Spandidos, D. A., Tsatsakis, A."Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review)". Molecular Medicine Reports 22, no. 1 (2020): 9-19. https://doi.org/10.3892/mmr.2020.11127
Copy and paste a formatted citation
x
Spandidos Publications style
Petrakis D, Margină D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, Kouretas D, Spandidos DA and Tsatsakis A: Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review). Mol Med Rep 22: 9-19, 2020.
APA
Petrakis, D., Margină, D., Tsarouhas, K., Tekos, F., Stan, M., Nikitovic, D. ... Tsatsakis, A. (2020). Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review). Molecular Medicine Reports, 22, 9-19. https://doi.org/10.3892/mmr.2020.11127
MLA
Petrakis, D., Margină, D., Tsarouhas, K., Tekos, F., Stan, M., Nikitovic, D., Kouretas, D., Spandidos, D. A., Tsatsakis, A."Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review)". Molecular Medicine Reports 22.1 (2020): 9-19.
Chicago
Petrakis, D., Margină, D., Tsarouhas, K., Tekos, F., Stan, M., Nikitovic, D., Kouretas, D., Spandidos, D. A., Tsatsakis, A."Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review)". Molecular Medicine Reports 22, no. 1 (2020): 9-19. https://doi.org/10.3892/mmr.2020.11127
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team